121 related articles for article (PubMed ID: 14673647)
1. Expression of insulin-like growth factor mitogenic signals in adult soft-tissue sarcomas: significant correlation with malignant potential.
Busund LT; Ow KT; Russell P; Crowe PJ; Yang JL
Virchows Arch; 2004 Feb; 444(2):142-8. PubMed ID: 14673647
[TBL] [Abstract][Full Text] [Related]
2. Significant expression of IGFBP2 in breast cancer compared with benign lesions.
Busund LT; Richardsen E; Busund R; Ukkonen T; Bjørnsen T; Busch C; Stalsberg H
J Clin Pathol; 2005 Apr; 58(4):361-6. PubMed ID: 15790698
[TBL] [Abstract][Full Text] [Related]
3. Insulin-like growth factor type 1 receptor expression correlates to good prognosis in highly malignant soft tissue sarcoma.
Ahlén J; Wejde J; Brosjö O; von Rosen A; Weng WH; Girnita L; Larsson O; Larsson C
Clin Cancer Res; 2005 Jan; 11(1):206-16. PubMed ID: 15671548
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical detection of hTERT protein in soft tissue sarcomas: correlation with tumor grade.
Sabah M; Cummins R; Leader M; Kay E
Appl Immunohistochem Mol Morphol; 2006 Jun; 14(2):198-202. PubMed ID: 16785790
[TBL] [Abstract][Full Text] [Related]
5. Proliferative activity (MIB-1 index) is an independent prognostic parameter in patients with high-grade soft tissue sarcomas of subtypes other than malignant fibrous histiocytomas: a retrospective immunohistological study including 216 soft tissue sarcomas.
Jensen V; Sørensen FB; Bentzen SM; Ladekarl M; Nielsen OS; Keller J; Jensen OM
Histopathology; 1998 Jun; 32(6):536-46. PubMed ID: 9675593
[TBL] [Abstract][Full Text] [Related]
6. Beta-catenin in soft tissue sarcomas: expression is related to proliferative activity in high-grade sarcomas.
Kuhnen C; Herter P; Müller O; Muehlberger T; Krause L; Homann H; Steinau HU; Müller KM
Mod Pathol; 2000 Sep; 13(9):1005-13. PubMed ID: 11007041
[TBL] [Abstract][Full Text] [Related]
7. Pitfalls in immunohistochemical assessment of EGFR expression in soft tissue sarcomas.
Kersting C; Packeisen J; Leidinger B; Brandt B; von Wasielewski R; Winkelmann W; van Diest PJ; Gosheger G; Buerger H
J Clin Pathol; 2006 Jun; 59(6):585-90. PubMed ID: 16461571
[TBL] [Abstract][Full Text] [Related]
8. High IGF2 and FGFR3 are associated with tumour progression in undifferentiated pleomorphic sarcomas, but EGFR and FGFR3 mutations are a rare event.
Rüping K; Altendorf-Hofmann A; Chen Y; Kampmann E; Gibis S; Lindner L; Katenkamp D; Petersen I; Knösel T
J Cancer Res Clin Oncol; 2014 Aug; 140(8):1315-22. PubMed ID: 24804818
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical and clinical evaluation of cathepsin expression in soft tissue sarcomas.
Würl P; Taubert H; Meye A; Dansranjavin T; Weber E; Günther D; Berger D; Schmidt H; Dralle H; Rath FW
Virchows Arch; 1997 Mar; 430(3):221-5. PubMed ID: 9099979
[TBL] [Abstract][Full Text] [Related]
10. Loss of p16(INK4a) is associated with reduced patient survival in soft tissue tumours, and indicates a senescence barrier.
Knösel T; Altendorf-Hofmann A; Lindner L; Issels R; Hermeking H; Schuebbe G; Gibis S; Siemens H; Kampmann E; Kirchner T
J Clin Pathol; 2014 Jul; 67(7):592-8. PubMed ID: 24747207
[TBL] [Abstract][Full Text] [Related]
11. Midkine enhances soft-tissue sarcoma growth: a possible novel therapeutic target.
Jin Z; Lahat G; Korchin B; Nguyen T; Zhu QS; Wang X; Lazar AJ; Trent J; Pollock RE; Lev D
Clin Cancer Res; 2008 Aug; 14(16):5033-42. PubMed ID: 18698021
[TBL] [Abstract][Full Text] [Related]
12. Expression of nm23 protein in adult soft tissue sarcoma is correlated with histological grade.
D'Souza RJ; Sheikh ZA; Busund LT; Russell PJ; Crowe PJ; Yang JL
Anticancer Res; 2003; 23(4):3289-94. PubMed ID: 12926065
[TBL] [Abstract][Full Text] [Related]
13. Expression of insulin-like growth factor pathway proteins in rhabdomyosarcoma: IGF-2 expression is associated with translocation-negative tumors.
Makawita S; Ho M; Durbin AD; Thorner PS; Malkin D; Somers GR
Pediatr Dev Pathol; 2009; 12(2):127-35. PubMed ID: 18788888
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of galectin-3 expression by sarcomas, pseudosarcomatous and benign lesions of the soft tissues. Preliminary results of an immunohistochemical study.
Bigotti G; Coli A; Del Vecchio M; Massi G
J Exp Clin Cancer Res; 2003 Jun; 22(2):255-64. PubMed ID: 12866576
[TBL] [Abstract][Full Text] [Related]
15. T-cell infiltration and clonality correlate with programmed cell death protein 1 and programmed death-ligand 1 expression in patients with soft tissue sarcomas.
Pollack SM; He Q; Yearley JH; Emerson R; Vignali M; Zhang Y; Redman MW; Baker KK; Cooper S; Donahue B; Loggers ET; Cranmer LD; Spraker MB; Seo YD; Pillarisetty VG; Ricciotti RW; Hoch BL; McClanahan TK; Murphy E; Blumenschein WM; Townson SM; Benzeno S; Riddell SR; Jones RL
Cancer; 2017 Sep; 123(17):3291-3304. PubMed ID: 28463396
[TBL] [Abstract][Full Text] [Related]
16. Quantitative immunohistochemical evaluation of MIB-1 labeling index in adult soft-tissue sarcomas by computer-assisted image analysis.
Hasegawa T; Yamamoto S; Matsuno Y
Pathol Int; 2002 Jul; 52(7):433-7. PubMed ID: 12167100
[TBL] [Abstract][Full Text] [Related]
17. LHRH receptor expression in sarcomas of bone and soft tissue.
Deivaraju C; Temple HT; Block N; Robinson P; Schally AV
Horm Mol Biol Clin Investig; 2016 Nov; 28(2):105-111. PubMed ID: 27639272
[TBL] [Abstract][Full Text] [Related]
18. High bad and bcl-xL gene expression and combined bad, bcl-xL, bax and bcl-2 mRNA levels: molecular predictors for survival of stage 2 soft tissue sarcoma patients.
Köhler T; Würl P; Meye A; Lautenschläger C; Bartel F; Borchert S; Bache M; Schmidt H; Holzhausen HJ; Taubert H
Anticancer Res; 2002; 22(3):1553-9. PubMed ID: 12168836
[TBL] [Abstract][Full Text] [Related]
19. Histological grading and MIB-1 labeling index of soft-tissue sarcomas.
Hasegawa T
Pathol Int; 2007 Mar; 57(3):121-5. PubMed ID: 17295643
[TBL] [Abstract][Full Text] [Related]
20. Chemokine receptor CXCR4 expression is correlated with VEGF expression and poor survival in soft-tissue sarcoma.
Oda Y; Tateishi N; Matono H; Matsuura S; Yamamaoto H; Tamiya S; Yokoyama R; Matsuda S; Iwamoto Y; Tsuneyoshi M
Int J Cancer; 2009 Apr; 124(8):1852-9. PubMed ID: 19107931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
